Application of botulinum toxin in strabismus treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022852

Enrollment

Unknown

Registered

2019-04-28

Start date

2019-07-01

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

strabismus

Interventions

Congenital esotropia:Botox injection

Acute common esotropia:Botox injection

Intermittent exotropia:Botox injection

Eligibility

Sex/Gender

All

Age

4 Years to No maximum

Inclusion criteria

Inclusion criteria: Participants: From July 2019 to December 2020, more than 50 patients with various strabismus such as small and medium-sized infants with esotropia, acute acquired esotropia, intermittent oblique external strabismus, and postoperative correction and undercorrection were enrolled in the applicant's unit.

Exclusion criteria

Exclusion criteria: Those with ocular infections; those who are unable to treat other systemic or eye diseases; those who do not agree with the treatment plan; those who cannot complete the follow-up.

Design outcomes

Primary

Measure	Time frame
Squint degree;Fusion range;Stereoscopic;	—

Countries

China

Contacts

Public ContactMinghua Shi

Wuhan Aier Eye Hospital (Hanyang)

13995559689@163.com+86 13995559689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026